Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

NME Half-Year Report: CDER Sets Strong Foundation With 14 Novel Approvals

Executive Summary

More than twice that number of novel agent applications have user fee goals coming up in the second half of 2015, putting FDA in good position to maintain its streak of high annual NME counts.

Advertisement

Related Content

FDA New Drug Approval Count May Fall Back To Earth In 2016
Biologics’ Big Bang: Novel BLAs Balance Breakthroughs And ‘Biobetters’

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS056974

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel